Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

British Biotech discontinues marimastat monotherapy study in ovarian cancer

Dec. 17, 1998

Liposome Co. files for approval of Evacet in U.S.

Dec. 17, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems

Dec. 16, 1998

Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.

Dec. 16, 1998

Clinical studies support excellent safety and efficacy of Busulfex

Dec. 15, 1998

New antitumor compounds presented by Kyorin

Dec. 15, 1998

Oxigene describes mechanism of action, therapeutic potential of declopramide

Dec. 15, 1998

Celgene acquires EntreMed rights to thalidomide

Dec. 14, 1998

AEterna signs CTA with NCI and reports lung cancer pivotal trial protocol details

Dec. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...